Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-26

Clinical Trial Update: World Maternal Antifibrinolytic Trial [Phase 3]

View source ↗

Summary

Phase 3 World Maternal Antifibrinolytic Trial (WOMAN) evaluating tranexamic acid for postpartum hemorrhage; completed with results showing reduced death due to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Postpartum Haemorrhage | Phase 3 | Status: COMPLETED